Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Alejandra Caqueo-Urízar, Alfonso Urzúa, Patricio Mena-Chamorro, Guillaume Fond & Laurent Boyer. (2020) Adherence to Antipsychotic Medication and Quality of Life in Latin-American Patients Diagnosed with Schizophrenia. Patient Preference and Adherence 14, pages 1595-1604.
Read now
Read now
Wen Ling Hsieh, Shih Kai Lee, Wai Tong Chien, Wen I Liu, Chien Yu Lai & Chieh Yu Liu. (2019) Mediating Effect Of The Motivation For Medication Use On Disease Management And Medication Adherence Among Community-Dwelling Patients With Schizophrenia. Patient Preference and Adherence 13, pages 1877-1887.
Read now
Read now
Jingping Zhao, Lehua Li, Jianguo Shi, Yi Li, Xiufeng Xu, Keqing Li, Lili Zhang, Shangli Cai, Yu Feng, Jianmin Zhuo, Weihong Liu & Huafei Lu. (2017) Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study. Neuropsychiatric Disease and Treatment 13, pages 2045-2056.
Read now
Read now
Eva G Katz, Brett Hauber, Srihari Gopal, Angie Fairchild, Amy Pugh, Rachel B Weinstein & Bennett S Levitan. (2016) Physician and patient benefit–risk preferences from two randomized long-acting injectable antipsychotic trials. Patient Preference and Adherence 10, pages 2127-2139.
Read now
Read now
Irma H. Mahone, Chris Fasching Maphis & Diane E. Snow. (2016) Effective Strategies for Nurses Empowering Clients With Schizophrenia: Medication Use as a Tool in Recovery. Issues in Mental Health Nursing 37:5, pages 372-379.
Read now
Read now
Alexandre González-Rodríguez, Rosa Catalán, Rafael Penadés, Clemente Garcia-Rizo, Miquel Bioque, Eduard Parellada & Miquel Bernardo. (2015) Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability – a review. Patient Preference and Adherence 9, pages 695-706.
Read now
Read now
Jingbo Xiao, Weifeng Mi, Lingzhi Li, Ying Shi & Hongyan Zhang. (2015) High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People’s Republic of China. Neuropsychiatric Disease and Treatment 11, pages 1161-1167.
Read now
Read now
Carmela J. Benson, Kruti Joshi, Kate L. Lapane & John Fastenau. (2015) Evaluation of a comprehensive information and assistance program for patients with schizophrenia treated with long-acting injectable antipsychotics. Current Medical Research and Opinion 31:7, pages 1437-1448.
Read now
Read now
Articles from other publishers (20)
Shuhei Wada, Kunihiro Iwamoto, Hiroki Okumura, Hirotake Hida, Shuichi Hiraoka, Aya Kamei, Daisuke Mori, Kiyofumi Yamada & Norio Ozaki. (2023) Sensory evaluation of the bitterness of asenapine using D-sorbitol pretreatment: single-blind, placebo-controlled, crossover trial. BMC Psychiatry 23:1.
Crossref
Crossref
Silvia Corchón, Vanessa Sánchez-Martínez & Omar Cauli. (2022) Perceived mental health and emotional trajectories of long-term family caregivers of persons with mental conditions: A mixed-methods study. Archives of Psychiatric Nursing 41, pages 105-113.
Crossref
Crossref
Pilar Lozano, Howard K. Butcher, Cecilia Serrano, Aurelio Carrasco, Carolina Lagares, Pilar Lusilla & Cristina O'Ferrall. (2021) Motivational interviewing: Validation of a proposed NIC nursing intervention in persons with a severe mental illness. International Journal of Nursing Knowledge 32:4, pages 240-252.
Crossref
Crossref
Junli Zhu, Qingzhi Huang, Wei Lu, Yun Chen, Bin Li, Ying Xu, Rui Xi & Dan Li. (2021) Do Community Free-Medication Service Policy Improve Patient Medication Adherence? A Cross-Sectional Study of Patients With Severe Mental Disorders in Beijing Community. Frontiers in Public Health 9.
Crossref
Crossref
Mohammed H. Elkomy. (2020) Changing the Drug Delivery System: Does it Add to Non-Compliance Ramifications Control? A Simulation Study on the Pharmacokinetics and Pharmacodynamics of Atypical Antipsychotic Drug. Pharmaceutics 12:4, pages 297.
Crossref
Crossref
Fiorenzo Santoleri, Ruggero Lasala, Andrea Logreco, Elena Ranucci & Alberto Costantini. (2018) Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukaemia. Journal of Oncology Pharmacy Practice 25:5, pages 1035-1041.
Crossref
Crossref
Emily J. Hauenstein, Rachael S. Clark & Elizabeth I. Merwin. (2018) Modeling Health Disparities and Outcomes in Disenfranchised Populations. Community Mental Health Journal 55:1, pages 9-23.
Crossref
Crossref
Ulrike Stentzel, Neeltje van den Berg, Lara N. Schulze, Thea Schwaneberg, Franziska Radicke, Jens M. Langosch, Harald J. Freyberger, Wolfgang Hoffmann & Hans-Jörgen Grabe. (2018) Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla). BMC Psychiatry 18:1.
Crossref
Crossref
Kevin A. Look & Jamie A. Stone. (2018) Medication management activities performed by informal caregivers of older adults. Research in Social and Administrative Pharmacy 14:5, pages 418-426.
Crossref
Crossref
Manli Huang, Liang Yu, Fen Pan, Shaojia Lu, Shaohua Hu, Jianbo Hu, Jinkai Chen, Pingbo Jin, Hongli Qi & Yi Xu. (2018) A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 81, pages 122-130.
Crossref
Crossref
Michele Virgolesi, Gianluca Pucciarelli, Anna Maria Colantoni, Fabio D'Andrea, Barbara Di Donato, Fabio Giorgi, Lidia Landi, Eleonora Salustri, Carlo Turci & Maria Grazia Proietti. (2017) The effectiveness of a nursing discharge programme to improve medication adherence and patient satisfaction in the psychiatric intensive care unit. Journal of Clinical Nursing 26:23-24, pages 4456-4466.
Crossref
Crossref
A. El Ammouri & H. Kisra. (2017) Étude de l’observance thérapeutique chez une population de patients atteints de schizophrénie au Maroc. L'Encéphale 43:6, pages 522-527.
Crossref
Crossref
KNagaraja Rao, Jitty George, CY Sudarshan & Shamshad Begum. (2017) Treatment compliance and noncompliance in psychoses. Indian Journal of Psychiatry 59:1, pages 69.
Crossref
Crossref
Goodman Sibeko, Peter D Milligan, Henk Temmingh, Crick Lund, Dan J Stein & Sumaya Mall. (2016) Caregiving for mental health service users: A study exploring the perceptions of mental health service users and their caregivers in Cape Town, South Africa. International Journal of Social Psychiatry 62:6, pages 512-521.
Crossref
Crossref
Stephanie V Phan. (2016) Medication adherence in patients with schizophrenia. The International Journal of Psychiatry in Medicine 51:2, pages 211-219.
Crossref
Crossref
Mei Hung Chi, Chih Yin Hsiao, Kao Chin Chen, Lan-Ting Lee, Hsin Chun Tsai, I Hui Lee, Po See Chen & Yen Kuang Yang. (2016) The readmission rate and medical cost of patients with schizophrenia after first hospitalization — A 10-year follow-up population-based study. Schizophrenia Research 170:1, pages 184-190.
Crossref
Crossref
Li-fen Chen, Jia Liu, Jing Zhang & Xiao-qin Lu. (2016) Non-pharmacological interventions for caregivers of patients with schizophrenia: A meta-analysis. Psychiatry Research 235, pages 123-127.
Crossref
Crossref
K. A. Kannisto, C. E. Adams, M. Koivunen, J. Katajisto & M. Va lima ki. (2015) Feedback on SMS reminders to encourage adherence among patients taking antipsychotic medication: a cross-sectional survey nested within a randomised trial. BMJ Open 5:11, pages e008574-e008574.
Crossref
Crossref
R. Lencer & D. Korn. (2015) Adhärenz in der PsychopharmakologieAdherence to psychopharmacological treatment. Der Nervenarzt 86:5, pages 637-648.
Crossref
Crossref
Martin Lambert, D. Schöttle, F. Ruppelt, D. Lüdecke, G. Sarikaya, M. Schulte-Markwort, J. Gallinat & A. Karow. (2015) Integrierte Versorgung für erst- und mehrfacherkrankte Patienten mit schweren psychotischen ErkrankungenIntegrated care for patients with first and multiple episodes of severe psychotic illnesses. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 58:4-5, pages 408-419.
Crossref
Crossref